| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | CA2027765C Mevinic acid derivatives |
| 04/12/2001 | WO2001025190A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | CN1291238A Process for obtaining of HMG-CO A reductase inhibitors of high purify |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/10/2001 | US6215016 Hematopoietic agents; preventing cytopenia |
| 04/10/2001 | US6215007 Recombinant production of novel polyketides |
| 04/10/2001 | US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease |
| 04/10/2001 | US6214872 Antiarthritic and anticarcinogenic agents |
| 04/10/2001 | US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production |
| 04/10/2001 | US6214573 Recombinant production of novel polyketides |
| 04/10/2001 | CA2056412C Discodermolide compounds, compositions containing same and methods of preparation and use |
| 04/04/2001 | EP1088844A1 Polyamide and process for producing the same |
| 04/04/2001 | EP1088553A1 Immunosuppressant containing glucopyranose derivative as active ingredient |
| 04/04/2001 | EP1088550A1 alpha-sulfonylamino hydroxamic acid inhibitors of matrix metallo-proteinases for the treatment of peripheral or central nervous system disorders |
| 04/04/2001 | EP1087958A1 Process to manufacture simvastatin and intermediates |
| 04/04/2001 | EP1087926A2 Analytic substrates and antioxidative agents |
| 04/04/2001 | CN1290261A process for producing simvastatin |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/03/2001 | US6211388 Method for producing propylene oxide |
| 04/03/2001 | US6211386 Hydrogenating precursor compound, the e-geometrical isomer thereof or a mixture of the z- and e-isomers in the presence of catalyst containing rh, a chiral ligand with at least one phosphorous atom |
| 04/03/2001 | US6211370 Asymmetric cycloaddition reactions |
| 04/01/2001 | CA2321593A1 .alpha.-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders |
| 03/28/2001 | EP1086112A2 1-galactose derivatives |
| 03/28/2001 | EP1086096A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 03/28/2001 | EP1086076A1 Sulfonamide inhibitors of aspartyl protease |
| 03/28/2001 | EP1086068A1 Optically active compounds |
| 03/28/2001 | CN1288891A Simple synthesis of 6-methyl-4-hydroxy-2-pyrone |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/27/2001 | US6207839 Process for preparing compositions useful as intermediates for preparing lubricating oil and fuel additives |
| 03/22/2001 | WO2001020334A1 Glucose sensing molecules having selected fluorescent properties |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
| 03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | DE19944763A1 Use of new and known 5,6-dihydro-4H-pyran-3-carboxamide derivatives as total or selective, pre- or post-emergence herbicides and as desiccants, defoliants and with fruit abscission inducing activity, is new |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | CA2381539A1 Glucose sensing molecules having selected fluorescent properties |
| 03/20/2001 | US6204222 Substituted cyclohexene-1,2-dicarboxylic acid derivatives and intermediates for their preparation |
| 03/20/2001 | US6204032 Method for producing pravastatin precursor, ML-236B |
| 03/20/2001 | CA2213111C Substituted carboxanilide derivative and plant disease control agent comprising same as active ingredient |
| 03/15/2001 | WO2001017983A2 Method for producing rose oxide using halohydrins or epoxides |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO2000047196A3 Use of statins for treating viral infections |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/15/2001 | DE19942997A1 Verfahren zur Herstellung von Rosenoxid über Halohydrine oder Epoxide Process for the preparation of rose oxide over halohydrins or epoxides |
| 03/14/2001 | EP0805800B1 Method for preparing (+)compactin and (+)mevinolin analog compounds having a beta-hydroxy-delta-lactone grouping |
| 03/08/2001 | WO2000058298A3 PROCESS FOR THE PREPARATION OF α-METHYLENELACTONES AND α-SUBSTITUTED HYDROCARBYLIDENE LACTONES |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/07/2001 | EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081132A1 Hydroxamic acid derivatives and medicinal utilization thereof |
| 03/07/2001 | CN1286633A Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 03/07/2001 | CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1062732C Use of compositions based on alpha-pyrones for inducing and stimulating hair growth and/or retarding hair loss |
| 03/06/2001 | US6197958 Carboxylic acid derivatives, their preparation and use |
| 03/06/2001 | US6197811 Synthetic derivatives of phomalactone, a known compound obtainable by fermentation of the fungus phomopsis sp, have activity as inhibitors of cytokine production in treatment of disorders requiring immunosuppression, for example |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/06/2001 | US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/01/2001 | WO2001014316A1 Substituted chiral allosteric hemoglobin modifiers |
| 03/01/2001 | WO2001014303A1 Triketone compounds, process for producing the same and herbicides containing the same |
| 03/01/2001 | CA2384511A1 Substituted chiral allosteric hemoglobin modifiers |
| 02/28/2001 | EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077765A1 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors |
| 02/28/2001 | CN1285835A Novel substituted phenyl keto enols |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | US6194585 Process for preparing 5-lipoxygenase inhibitors |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | DE19939645A1 New 1,3-bis(2,3-dihydroxybenzoylamino) substituted (hetero)aromatic siderophore compounds useful as bacterial growth factors and chemotherapeutic agents, e.g. for treatment of Alzheimer's disease |
| 02/22/2001 | CA2698353A1 Pharmaceutical compounds |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/21/2001 | EP0734382B1 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation |
| 02/20/2001 | US6191288 Alkylating pyrone with an alkyl halide to form an intermediate, deprotecting the first intermediate to form second intermediate; useful intermeidate for myxopyronins and corallopyronins antibiotics |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/15/2001 | WO2001010826A1 Substituted aromatic-ring compounds, process for producing the same, and use |
| 02/15/2001 | WO2001010433A1 Neuropathy improvers containing nitrogenous compounds as the active ingredient |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | CA2382759A1 Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient |
| 02/15/2001 | CA2380990A1 Substituted aromatic-ring compounds, process for producing the same, and use |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/13/2001 | US6187933 Bind to retinoid receptors; treating skin disorders |
| 02/13/2001 | US6187924 Inhibitors of matrix metalloproteinases and/or tumor necrosis factor-alpha-mediated diseases |
| 02/13/2001 | US6187762 Fucoside containing polymer |
| 02/13/2001 | US6187741 Process for preparing saturated lactones, products produced therefrom and organoleptic uses of said products |
| 02/08/2001 | WO2001009093A1 Benzenamine derivatives as anti-coagulants |
| 02/08/2001 | WO2001009089A1 Process for the preparation of isotretinoin |
| 02/08/2001 | WO2000069855A3 Furanone derivatives as inhibitors of cathepsin s |
| 02/08/2001 | CA2380029A1 Benzenamine derivatives as anti-coagulants |
| 02/08/2001 | CA2380026A1 Process for the preparation of isotretinoin |
| 02/07/2001 | EP1074541A1 Method for manufacturing aminoalcohol |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |